FDA Inspection 795971 — Hans Biomed Corporation

Hans Biomed Corporation — FEI 3003828812

The FDA completed an inspection of Hans Biomed Corporation on June 29, 2012 in Yuseong District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 29, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Yuseong District (Korea (the Republic of))